Loading...

Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancers (NSCLC) account for 85–90% of all lung cancers. As drug resistance critically impairs chemotherapy effectiveness, there is great need to identify new therapeutic targets. The aims of this study were to investigate the prognostic and therapeutic potential of th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Cancer
Main Authors: Suraweera, Amila, Duff, Alex, Adams, Mark N., Jekimovs, Christian, Duijf, Pascal H. G., Liu, Cheng, McTaggart, Matthew, Beard, Sam, O’Byrne, Kenneth J., Richard, Derek J.
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group UK 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7434762/
https://ncbi.nlm.nih.gov/pubmed/32439936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0899-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!